GlassScriptPhysician profile
Neil Eric Brown
NPI 1457332934
$1,503.27
in general payments reported to CMS, 2019-2025
8 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $241 · 2021: $124 · 2022: $69.55 · 2023: $128 · 2024: $451 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $723.96 | 2019-2024 | Acclarent Aera, Trudi Nav Cable |
| Integra Lifesciences Corporation | $348.43 | 2024-2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Intersect Ent, INC. | $186.24 | 2019 | |
| Cochlear Americas | $128.19 | 2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Stryker Corporation | $42.67 | 2021-2024 | Scopis Ent |
| Becton, Dickinson and Company | $37.41 | 2025 | Hemaderm |
| Preceptis Medical, INC. | $22.36 | 2021 | |
| Smith+Nephew, INC. | $14.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.